RISK MANAGEMENT

Grounded in Prudence, Growing with Preparedness.

In a highly regulated pharmaceutical landscape, we adopt a disciplined approach to risk governance to ensure product quality, patient safety, and compliance. The Board defines our risk appetite and retains overall oversight. The Risk Management Committee provides direction and monitors key risks, while the Audit Committee evaluates the effectiveness of internal controls. This is reinforced through periodic internal and external audits.

Enterprise Risk Management Framework

Our ERM framework enables a structured enterprise-wide approach to identifying, assessing, and mitigating risks. It supports informed decision-making, strengthens resilience, and aligns risk management with strategic priorities.

Risk Management Approach

Identify -

Enterprise-wide processes capture internal and external risks through cross-functional inputs.

Define -

Risk appetite guides balanced and consistent decision-making.

Assess -

Tools such as risk registers, scenario analysis, and key indicators help prioritise risks.

Mitigate -

Targeted controls, including quality systems, pharmacovigilance, compliance, and continuity planning, manage key risks.

Monitor -

Ongoing review and reporting enable timely action and continuous improvement.

How We Manage Risk

Operational Risks

Capacity Planning and Optimisation Risk

Inadequate capacity alignment with evolving demand patterns may constrain responsiveness and impact margins.

Capitals Impacted
Stakeholder Impacted
Strategic Priorities

S2 - Excel | S3 - Expand

Risk Owner

Operations / Supply Chain

Oversight

Risk Management Committee; Board

Mitigating Measures
  • Strengthening demand forecasting through data-led planning tools
  • Enhancing capacity flexibility across manufacturing sites
  • Monitoring input cost exposures and deploying structured hedging mechanisms

Environment, Health and Safety (EHS)

Stringent and evolving EHS regulations across geographies may impact operational continuity and compliance.

Capitals Impacted
Stakeholder Impacted
Strategic Priorities

S2 - Excel

Risk Owner

Operations / EHS

Oversight

Risk Management Committee; Board

Mitigating Measures
  • Advancing sustainable operations and resource efficiency initiatives
  • Reinforcing safety culture through continuous training and awareness programmes
  • Strengthening process safety systems for high-risk operations

Operating Risk

Inefficiencies in managing vendor and customer relationships may affect revenue stability and operational efficiency.

Capitals Impacted
Stakeholder Impacted
Strategic Priorities

S2 - Excel

Risk Owner

Supply Chain / Commercial

Oversight

Risk Management Committee

Mitigating Measures
  • Diversifying supplier base to reduce single-source dependency
  • Strengthening long-term partnerships across the value chain
  • Leveraging digital tools for better coordination and visibility

Financial Risk

Foreign Exchange Rate Risk

Exposure to multiple currencies across revenues, costs, and investments may lead to earnings volatility.

Capitals Impacted
Stakeholder Impacted
Strategic Priorities

S2 - Excel

Risk Owner

Finance / Treasury

Oversight

Audit Committee

Mitigating Measures
  • Implementing a disciplined and structured hedging framework
  • Continuously monitoring currency movements and exposures
  • Aligning treasury strategies with evolving market conditions

Compliance Risk

Regulatory Risk

Non-compliance with evolving regulatory requirements may disrupt operations and delay product approvals.

Capitals Impacted
Stakeholder Impacted
Strategic Priorities

S2 - Excel

Risk Owner

Quality / Regulatory Affairs

Oversight

Audit Committee; Board

Mitigating Measures
  • Maintaining robust compliance and quality management systems
  • Engaging proactively with regulatory authorities
  • Ensuring continuous monitoring of evolving regulatory requirements

Strategic Risks

Industry Risks

Macroeconomic shifts or industry downturns may adversely affect demand and growth momentum.

Capitals Impacted
Stakeholder Impacted
Strategic Priorities

S2 - Excel | S3 - Expand

Risk Owner

Strategy / Leadership Team

Oversight

Board

Mitigating Measures
  • Expanding presence across key and emerging markets
  • Diversifying portfolio to enhance business resilience
  • Embedding business continuity planning across operations
Innovation Risk

Limited differentiation in products or processes may constrain long-term growth and competitiveness.

Capitals Impacted
Stakeholder Impacted
Strategic Priorities

S1 - Innovate

Risk Owner

R&D

Oversight

Risk Management Committee; Board

Mitigating Measures
  • Increasing investments in R&D and product development
  • Accelerating commercialisation of niche and value-added products
  • Leveraging advanced capabilities to drive process innovation
Competition Risk

Intensifying competition in domestic and global markets may impact market share and pricing power.

Capitals Impacted
Stakeholder Impacted
Strategic Priorities

S1 - Innovate | S2 - Excel

Risk Owner

Commercial / Strategy

Oversight

Leadership Team

Mitigating Measures
  • Driving cost optimisation across operations
  • Enhancing product differentiation and value proposition
  • Strengthening customer engagement through quality and service excellence